HDM1002
HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects
Huadong Medicine · Phase 1 · Status n/r · Enrollment 72
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| HDM1002 100 mg | n/r | n/r | n/r | n/r |
| HDM1002 200 mg | n/r | n/r | n/r | n/r |
| HDM1002 400 mg | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- HDM1002 100 mg: endpoint not reported
- HDM1002 200 mg: endpoint not reported
- HDM1002 400 mg: endpoint not reported
- Placebo: endpoint not reported